AstraZeneca, a global pharmaceutical company, is supporting some selected Ghanaian health facilities to improve paediatric and adult asthma care and management, Mr Emmanuel Atiemo Mawuli, the Country Manager, has stated.
He said this was being done under the AstraZeneca Africa PUMUA Initiative, which sought to redefine asthma care in Ghana.
The Ghana Health Service (GHS), Ghana Thoracic Society (GTS), Pharmaceutical Society of Ghana and some local health providers and respiratory health experts are collaborating with the pharmaceutical company to achieve the objectives of the Initiative in country.
Mr Emmanuel Atiemo Mawuli, the Country Manager, AstraZeneca, in an interview with the Ghana News Agency (GNA), Kumasi, on the side-line of the donation of nebulizers to some health facilities, said it was imperative for those at risk of or who were living with asthma to have timely access to healthcare services.
A nebulizer is an electrically powered machine that turns liquid medication into a mist so that it can be breathed directly into the lungs through a face mask or mouthpiece.
The Africa PUMUA Initiative, therefore, is committed to improving the health outcomes of patients on the continent by providing the needed support for infrastructure, and also in creating awareness on the symptoms and risks of asthma.
Mr Mawuli assured that AstraZeneca, through the Initiative, would help to build the capacity of all role players across the patient journey, while addressing the barriers currently preventing access to care for patients with asthma.